Cargando…
Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2
In Coronavirus disease 2019 (COVID-19), a decreased number of regulatory T (Treg) cells and their mediated factors lead to a hyperinflammatory state due to overactivation of the inflammatory cells and factors during the infection. In the current study, we evaluated the Nanocurcumin effects on the Tr...
Autores principales: | Tahmasebi, Safa, Saeed, Balsam Qubais, Temirgalieva, Elmira, Yumashev, Alexei Valerievich, El-Esawi, Mohamed A., Navashenaq, Jamshid Gholizadeh, Valizadeh, Hamed, Sadeghi, Armin, Aslani, Saeed, Yousefi, Mehdi, Jadidi-Niaragh, Farhad, Adigozalou, Javad, Ahmadi, Majid, Roshangar, Leila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005319/ https://www.ncbi.nlm.nih.gov/pubmed/33789145 http://dx.doi.org/10.1016/j.lfs.2021.119437 |
Ejemplares similares
-
Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function
por: Abbaspour-Aghdam, Sanaz, et al.
Publicado: (2022) -
The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?
por: Gowhari Shabgah, Arezoo, et al.
Publicado: (2022) -
The prognostic and therapeutic potential of HO-1 in leukemia and MDS
por: Sadeghi, Mohammad, et al.
Publicado: (2023) -
Association of the matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of coronavirus disease 2019 (COVID-19); implications of contribution for development of neurological symptoms in the COVID-19 patients
por: Ramezani, Samaneh, et al.
Publicado: (2022) -
The molecular biology and therapeutic potential of Nrf2 in leukemia
por: Khodakarami, Atefeh, et al.
Publicado: (2022)